Vistin Pharma investor relations material

Vistin Pharma AS is a global pharmaceutical company that produces and markets active pharmaceutical ingredients. The company offers its products to an extensive network of third party manufacturers. In addition, the company develops its own formulations that are produced and marketed by the Vistin Pharma AS subsidiary. As well as producing bulk APIs, Vistin Pharma has a wide range of products in different stages of development that it expects will be launched in 2016. Vistin Pharma has experienced continued growth in demand for its products, both due to the expansion of the pharma industry and from the increasing amount of specialised niche pharmaceuticals being developed. Its focus is on supplying products for diabetes and autoimmunity therapies as well as antibiotics. The company was incorporated in 2015 and is headquartered in Oslo, Norway.